Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CELL | PhenomeX Inc.

Index	-	P/E	-	EPS (ttm)	-1.54	Insider Own	2.60%	Shs Outstand	98.90M	Perf Week	0.67%
Market Cap	98.26M	Forward P/E	-	EPS next Y	-0.59	Insider Trans	0.00%	Shs Float	87.33M	Perf Month	6.13%
Income	-124.50M	PEG	-	EPS next Q	-0.23	Inst Own	72.20%	Short Float / Ratio	2.01% / 1.09	Perf Quarter	85.72%
Sales	71.80M	P/S	1.37	EPS this Y	-32.40%	Inst Trans	-0.72%	Short Interest	1.76M	Perf Half Y	-18.56%
Book/sh	1.13	P/B	0.88	EPS next Y	48.70%	ROA	-53.00%	Target Price	1.00	Perf Year	-69.14%
Cash/sh	0.31	P/C	3.17	EPS next 5Y	-	ROE	-87.50%	52W Range	0.38 - 3.65	Perf YTD	-62.93%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-60.60%	52W High	-72.78%	Beta	0.89
Dividend %	-	Quick Ratio	1.30	Sales past 5Y	-	Gross Margin	64.70%	52W Low	161.40%	ATR	0.03
Employees	285	Current Ratio	2.20	Sales Q/Q	-26.60%	Oper. Margin	-	RSI (14)	70.81	Volatility	0.82% 1.08%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-34.10%	Profit Margin	-	Rel Volume	0.58	Prev Close	0.99
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Aug 14 AMC	Payout	-	Avg Volume	1.61M	Price	0.99
Recom	3.00	SMA20	2.34%	SMA50	29.81%	SMA200	-23.22%	Volume	934,071	Change	0.33%

Sep-21-23 08:35AM	PhenomeX Announces the Release of SpotLight Human Lambda Reagent for the Beacon® Platform to Accelerate Cell Line Development Workflows (PR Newswire)
Sep-20-23 08:48AM	PhenomeX to Participate in Upcoming Cell Biology Conferences (PR Newswire)
Sep-15-23 09:08AM	PhenomeX Unveils Meteor Chips For Quantitative Bulk Analysis On The IsoSpark Platform To Revolutionize High Throughput Multiplexed Hands-Free Proteomics (PR Newswire)
Sep-05-23 04:02PM	PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker (PR Newswire)
Aug-23-23 09:38AM	Super Micro raised, Dick's Sporting downgraded: Wall Street's top analyst calls (The Fly)
09:00AM	Loading…
Aug-17-23 09:00AM	Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction (Business Wire) +136.25%
Aug-14-23 04:05PM	PhenomeX Reports Second Quarter 2023 Financial Results and Provides Business Update (PR Newswire)
Aug-09-23 04:25PM	PhenomeX to Report Second Quarter 2023 Financial Results on August 14, 2023 (PR Newswire)
Aug-07-23 08:11AM	PhenomeX Announces Lifting of the Stay in AbCellera Patent Infringement Case (PR Newswire)
Jun-13-23 09:32AM	PhenomeX's Beacon® Technology Enables Early Identification of Potent Omicron-Neutralizing Antibodies (PR Newswire) +9.94%
Jun-05-23 08:46AM	PhenomeX Launches Beacon Quest Optofluidic System with Opto® T Cell Profiling Workflows (PR Newswire) -5.80%
May-16-23 06:03AM	PhenomeX Inc. (NASDAQ:CELL) Analysts Just Trimmed Their Revenue Forecasts By 17% (Simply Wall St.) -8.44%
May-15-23 09:01AM	PhenomeX Launches Beacon Select Optofluidic System with Opto® B Discovery Workflows (PR Newswire) +6.16%
May-11-23 04:02PM	PhenomeX Reports First Quarter 2023 Financial Results (PR Newswire) -12.39%
09:35AM	PhenomeX To Participate in 19th Annual PEGS Boston Conference & Expo (PR Newswire)
05:27PM	Loading…
Apr-27-23 05:27PM	PhenomeX to Report First Quarter 2023 Financial Results on May 11, 2023 (PR Newswire)
Apr-18-23 07:57AM	Not Many Are Piling Into PhenomeX Inc. (NASDAQ:CELL) Just Yet (Simply Wall St.) +7.25%
Apr-17-23 07:30AM	PhenomeX Launches the Opto® T Cell Profiling Workflow (PR Newswire)
Apr-10-23 08:35AM	PhenomeX Appoints Peter Silvester to PhenomeX Board of Directors (PR Newswire) -5.89%
Apr-07-23 08:35AM	PhenomeX to Participate in American Association of Cancer Research Annual Meeting 2023 (PR Newswire)

PhenomeX Inc. operates as a functional cell biology company. The company enables scientists to reveal insights on cell function and obtain behavior of each cell. Its suite of tools and services offer unparalleled resolution and speed, accelerating the insights for advancing discoveries that can profoundly improve the prevention and treatment of disease. The company's platforms are used by researchers worldwide, including pharmaceutical companies and comprehensive cancer centers. PhenomeX Inc. is headquartered in Emeryville, California.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CELL | PhenomeX Inc.

Upgrade your FINVIZ experience